We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IART icon
2001
Integra LifeSciences
IART
$1.54B
-12,603
Closed -$595K
ICFI icon
2002
ICF International
ICFI
$1.44B
-94,180
Closed -$5.79M
ICLR icon
2003
Icon
ICLR
$12.8B
-1,576
Closed -$301K
IDA icon
2004
Idacorp
IDA
$8.23B
-57,783
Closed -$4.62M
IEP icon
2005
Icahn Enterprises
IEP
$5.17B
-62,202
Closed -$3.07M
BRSL
2006
Brightstar Lottery PLC
BRSL
$1.91B
-100,417
Closed -$1.12M
ILMN icon
2007
Illumina
ILMN
$29.4B
-108,310
Closed -$32.6M
INSM icon
2008
Insmed
INSM
$23.2B
-26,757
Closed -$860K
INSW icon
2009
International Seaways
INSW
$4.57B
-72,620
Closed -$1.06M
INZY
2010
DELISTED
Inozyme Pharma
INZY
-12,418
Closed -$326K
IOSP icon
2011
Innospec
IOSP
$2.09B
-13,260
Closed -$840K
IOVA icon
2012
Iovance Biotherapeutics
IOVA
$2.23B
-58,026
Closed -$1.91M
IRM icon
2013
Iron Mountain
IRM
$38.2B
-74,995
Closed -$2.01M
IRT icon
2014
Independence Realty Trust
IRT
$3.92B
-74,533
Closed -$864K
IRWD icon
2015
Ironwood Pharmaceuticals
IRWD
$611M
-174,084
Closed -$1.56M
IYT icon
2016
iShares US Transportation ETF
IYT
$2.33B
-76,232
Closed -$3.79M
JBL icon
2017
Jabil
JBL
$32.8B
-20,736
Closed -$710K
JEF icon
2018
Jefferies Financial Group
JEF
$12.9B
-170,690
Closed -$2.94M
JELD icon
2019
JELD-WEN Holding
JELD
$94.8M
-11,631
Closed -$263K
JNJ icon
2020
Johnson & Johnson
JNJ
$635B
-16,295
Closed -$2.43M
JNPR
2021
DELISTED
Juniper Networks
JNPR
-42,586
Closed -$916K
JOUT icon
2022
Johnson Outdoors
JOUT
$482M
-9,244
Closed -$757K
KE
2023
Kimball Electronics
KE
$598M
-12,224
Closed -$141K
KELYA icon
2024
Kelly Services Class A
KELYA
$526M
-24,947
Closed -$425K
KEX icon
2025
Kirby Corp
KEX
$7.95B
-96,334
Closed -$3.48M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.